Phase IV Study in Parkinson’s Disease Patients Treated With XADAGO (Safinamide)

Condition:   Idiopathic Parkinson Disease
Intervention:   Drug: XADAGO (safinamide)
Sponsor:   US WorldMeds LLC
Recruiting
ClinicalTrials.gov: Neurology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days